We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M Turnover 28.57%
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+6.52%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$138M
AUM Growth
–
Cap. Flow
+$63.4M
Cap. Flow %
45.95%
Top 10 Hldgs %
47.95%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Buys

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$4.38M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.25M
3
AZN icon
AstraZeneca
AZN
+$4.19M
4
DGX icon
Quest Diagnostics
DGX
+$4M
5
ARAY icon
Accuray
ARAY
+$3.42M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 60.07%
2 Healthcare 39.54%
3 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$76.2B
$19.4M 14.07%
+200,000
New +$19.1M
2013 Q2
0 quarters
MRK icon
2
CALL
Merck
MRK
$360B
$9.29M 6.74%
+209,600
New +$9.36M
2013 Q2
0 quarters
TEVA icon
3
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
$6.66M 4.83%
+170,000
New +$6.62M
2013 Q2
0 quarters
MDY icon
4
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.3B
$5.25M 3.81%
+25,000
New +$5.29M
2013 Q2
0 quarters
SUPN icon
5
Supernus Pharmaceuticals
SUPN
$2.21B
$4.64M 3.37%
+722,314
New +$4.25M
2013 Q2
0 quarters
AUXL
6
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$4.57M 3.31%
+274,481
New +$4.38M
2013 Q2
0 quarters
IBB icon
7
PUT
iShares Biotechnology ETF
IBB
$10.3B
$4.35M 3.15%
+75,000
New +$4.34M
2013 Q2
0 quarters
DGX icon
8
Quest Diagnostics
DGX
$25.9B
$4.08M 2.95%
+67,208
New +$4M
2013 Q2
0 quarters
SPY icon
9
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$4.01M 2.91%
+25,000
New +$4.03M
2013 Q2
0 quarters
ARAY icon
10
Accuray
ARAY
$18.6M
$3.89M 2.82%
+677,749
New +$3.42M
2013 Q2
0 quarters
AZN icon
11
AstraZeneca
AZN
$257B
$3.89M 2.82%
+82,239
New +$4.19M
2013 Q2
0 quarters
ENDP
12
PUT
DELISTED
Endo International plc
ENDP
$3.68M 2.67%
+100,000
New +$3.59M
2013 Q2
0 quarters
FRX
13
DELISTED
FOREST LABORATORIES INC
FRX
$3.5M 2.54%
+85,382
New +$3.3M
2013 Q2
0 quarters
HUM icon
14
Humana
HUM
$49.6B
$3.38M 2.45%
+40,100
New +$3.17M
2013 Q2
0 quarters
CAH icon
15
Cardinal Health
CAH
$58.8B
$3.3M 2.39%
+69,886
New +$3.19M
2013 Q2
0 quarters
SUPN icon
16
CALL
Supernus Pharmaceuticals
SUPN
$2.21B
$2.89M 2.1%
+450,000
New +$2.65M
2013 Q2
0 quarters
TECH icon
17
Bio-Techne
TECH
$11.4B
$2.76M 2%
+160,000
New +$2.66M
2013 Q2
0 quarters
ANIP icon
18
ANI Pharmaceuticals
ANIP
$1.66B
$2.54M 1.85%
+374,111
New +$2.62M
2013 Q2
0 quarters
AUXL
19
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$2.5M 1.81%
+150,000
New +$2.4M
2013 Q2
0 quarters
ALXN
20
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$2.31M 1.67%
+25,000
New +$2.41M
2013 Q2
0 quarters
GSK icon
21
GSK
GSK
$99.2B
$2.3M 1.67%
+36,773
New +$2.33M
2013 Q2
0 quarters
SGNT
22
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.16M 1.57%
+102,922
New +$1.84M
2013 Q2
0 quarters
FRX
23
CALL
DELISTED
FOREST LABORATORIES INC
FRX
$2.05M 1.49%
+50,000
New +$1.93M
2013 Q2
0 quarters
OFIX icon
24
Orthofix Medical
OFIX
$382M
$1.92M 1.39%
+71,200
New +$2.13M
2013 Q2
0 quarters
ELV icon
25
Elevance Health
ELV
$92.9B
$1.85M 1.34%
+22,638
New +$1.69M
2013 Q2
0 quarters
1
2 3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Healthcare Value Capital, which disclosed 56 positions worth $138M. Its ten largest holdings account for 48% of the portfolio.

Its largest position is AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, followed by Healthcare and Industrials.

  • Healthcare Value Capital's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.
  • Healthcare Value Capital's ten largest holdings make up 48% of its $138M portfolio in Q2 2013.
  • Healthcare Value Capital disclosed 56 positions in Q2 2013, its first 13F filing on record.

Based on Healthcare Value Capital's 13F filing for Q2 2013, filed 8 Aug 2013.